Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-27 @ 11:17 PM
Study NCT ID:
NCT05007093
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-07
First Post:
2021-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib
Sponsor:
Yansong Lin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-09
First Submit QC Date:
None
Study First Post Date:
2021-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-05
Last Update Post Date:
2024-11-07
Last Update Post Date Type:
ACTUAL